| __timestamp | Sarepta Therapeutics, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 94231000 | 11768000 |
| Thursday, January 1, 2015 | 146394000 | 15152000 |
| Friday, January 1, 2016 | 188272000 | 19828000 |
| Sunday, January 1, 2017 | 166707000 | 25573000 |
| Monday, January 1, 2018 | 401843000 | 23634000 |
| Tuesday, January 1, 2019 | 560909000 | 38845000 |
| Wednesday, January 1, 2020 | 722343000 | 50523000 |
| Friday, January 1, 2021 | 771182000 | 75463000 |
| Saturday, January 1, 2022 | 877090000 | 105767000 |
| Sunday, January 1, 2023 | 877387000 | 167512000 |
Data in motion
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Sarepta Therapeutics, Inc. and Xenon Pharmaceuticals Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Sarepta Therapeutics has consistently increased its R&D expenses, peaking in 2022 with a staggering 877 million dollars, reflecting a nearly tenfold increase from 2014. This aggressive investment underscores Sarepta's dedication to advancing its pipeline of genetic medicine. In contrast, Xenon Pharmaceuticals, while also increasing its R&D spending, has done so at a more modest pace, reaching 168 million dollars in 2023, a fourteenfold increase from 2014.
These trends highlight the varying approaches within the biotech sector, where strategic R&D investments can significantly influence a company's trajectory and impact on healthcare innovation.
Bristol-Myers Squibb Company vs Sarepta Therapeutics, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Xenon Pharmaceuticals Inc.
United Therapeutics Corporation or Sarepta Therapeutics, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Xenon Pharmaceuticals Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Sarepta Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Xenon Pharmaceuticals Inc. and Soleno Therapeutics, Inc.
Analyzing R&D Budgets: Xenon Pharmaceuticals Inc. vs Amphastar Pharmaceuticals, Inc.